Hypertension Drugs 麻豆原创s in China

Publication ID:

AMID1019021

Publication Date:

October 11, 2019

Pages:

215

Publisher:

Asia 麻豆原创 Information & Development Co.

Countries:

China [1]

USD 4,000.00

Pharmaceutical Manufacturing [2]

Pharma & Healthcare [3]

Description:

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments鈥� industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table Of Contents:

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

Hypertension Drugs Industry Structure
麻豆原创 Size
麻豆原创 Growth Drivers
Hypertension Drugs Sales Volume
Major Producer Facility Locations
Major Producers鈥� Sales Volume and 麻豆原创 Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

麻豆原创 Overview by Drugs Classification

Calcium Channel Blocker
Felodipine
Nifedipine
Amlodipine
Nisoldipine
Nimodipine
Nitrendipine
Angiotensin 鈪� Receptor Antagonists Drug
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan
Angiotensin-Converting Enzyme Inhibitor
Benazepril
Enalapril
Captopril
Lisinopril
Ramipril

Other Hypertension Drugs
Import and Export

麻豆原创 Overview by Producers

Pricing Trend

V. HYPERTENSION DRUGS MARKET OUTLOOK

Hypertension Drugs 麻豆原创s Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Northeast
North
Southeast
Central
Southwest
Northwest

Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

China 麻豆原创 Entry Overview
China's Distribution System
Rubber Processing Chemicals Distribution Channels
Transportation and Freight Infrastructure
Communications
China鈥檚麻豆原创 Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. HYPERTENSION DRUGS PRODUCER DIRECTORY

Profiles of Hypertension Drugs Producers and Major Consumption in Industry

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

Calcium Channel Blocker Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor Sales Volume and 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs Sales Volume and 麻豆原创 Share by Drugs Classification
Hypertension Drugs Sales Volume
Major Producer Facility Location
Major Hypertension Drugs Producer Sales Volume
Major Foreign Investment in China

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

Hypertension Drugs Sales Volume by Drugs Classification
Calcium Channel Blocker Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug Sales Volume and 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor Sales Volume and 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs Sales Volume and 麻豆原创 Share by Drugs Classification
Hypertension Drugs Import by Drugs Classification
Hypertension Drugs Export by Drugs Classification
Hypertension Drugs Major Producer, Sales Volume, and 麻豆原创 Share

V. HYPERTENSION DRUGS MARKET OUTLOOK

Consumer Spending Trends
The Structure of Per Capita Expenditure in the Northeast of China
The Structure of Per Capita Expenditure in the North of China
The Structure of Per Capita Expenditure in the Southeast of China
The Structure of Per Capita Expenditure in the Central of China
The Structure of Per Capita Expenditure in the Southwest of China
The Structure of Per Capita Expenditure in the Northwest of China
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

Hypertension Drugs Sales Volume

II. BUSINESS ENVIRONMENT

China鈥檚 GDP and Growth Rate
Industrial Output by Ownership
China鈥檚 Imports and Exports

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

Total Hypertension Drugs Sales Volume
Hypertension Drugs Sales Volume by Drugs Classification
Calcium Channel Blocker 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs 麻豆原创 Share by Drugs Classification
Hypertension Drugs Sales Volume

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

Hypertension Drugs Sales Volume
Hypertension Drugs Import
Hypertension Drugs Export
Hypertension Drugs Sales Volume by Drugs Classification
Calcium Channel Blocker Sales Volume and 麻豆原创 Share
Calcium Channel Blocker 麻豆原创 Share by Drugs Classification
Angiotensin 鈪� Receptor Antagonists Drug Sales Volume and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug 麻豆原创 Share by Drugs Classification
Angiotensin-Converting Enzyme Inhibitor Sales Volume and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor 麻豆原创 Share by Drugs Classification
Other Hypertension Drugs Sales Volume and 麻豆原创 Share
Other Hypertension Drugs 麻豆原创 Share by Drugs Classification
Hypertension Drugs Import by Drugs Classification
Calcium Channel Blocker Import and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug Import and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor Import and 麻豆原创 Share
Other Hypertension Drugs Import and 麻豆原创 Share
Hypertension Drugs Export by Drugs Classification
Calcium Channel Blocker Export and 麻豆原创 Share
Angiotensin-Converting Enzyme Inhibitor Export and 麻豆原创 Share
Angiotensin 鈪� Receptor Antagonists Drug Export and 麻豆原创 Share
Other Hypertension Drugs Export and 麻豆原创 Share

VI. MARKETING STRATEGIES

China鈥檚 Distribution Channel

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.